Fidelis Capital Partners, LLC Trans Medics Group, Inc. Transaction History
Fidelis Capital Partners, LLC
- $654 Billion
- Q1 2024
A detailed history of Fidelis Capital Partners, LLC transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Fidelis Capital Partners, LLC holds 478 shares of TMDX stock, worth $70,361. This represents 0.08% of its overall portfolio holdings.
Number of Shares
478Holding current value
$70,361% of portfolio
0.08%Shares
1 transactions
Others Institutions Holding TMDX
# of Institutions
289Shares Held
29.1MCall Options Held
338KPut Options Held
370K-
Black Rock Inc. New York, NY2.52MShares$371 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.89MShares$278 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C31.3MShares$191 Million0.11% of portfolio
-
Driehaus Capital Management LLC Chicago, IL1.28MShares$189 Million1.04% of portfolio
-
Invesco Ltd. Atlanta, GA1.28MShares$189 Million0.02% of portfolio
About TransMedics Group, Inc.
- Ticker TMDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 31,831,400
- Market Cap $4.69B
- Description
- TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...